Clinical trial
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in…
NCT00495924 · KU Leuven, Other · Completed
Key facts
| NCT number | NCT00495924 |
|---|---|
| Title | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma |
| Official title | Prognostic Relevance of Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma |
| Lead sponsor | KU Leuven, Other |
| Collaborators | Research Foundation Flanders Agentschap voor Innovatie door Wetenschap en Technologie |
| Status | Completed |
| Study type | Observational |
| Conditions | Pancreatic Neoplasms, Adenocarcinoma, Neoplasm Circulating Cells, Tumor Markers, Biological, Monitoring, Immunologic |
| Intervention type | Procedure |
| Interventions | Pancreatic resection (PD) |
| Enrollment | 100 |
| Start date | Oct 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | Jul 8, 2009 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: